In our study, the occurrence of MAP3K mutations, emerging either during or after the completion of adjuvant ET, was the only covariate significantly associated with worse prognosis in a multivariable Cox model including clinically relevant patient- and tumor-related variables, such as menopausal status, T and N stage, tumor grade and Ki-67 labelling index. The gene discussed is MKI67; the disease is neoplasm.